X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50) 50
index medicus (45) 45
female (42) 42
male (41) 41
middle aged (38) 38
aged (35) 35
life sciences (29) 29
critical care medicine (27) 27
intensive care units (24) 24
prospective studies (20) 20
prognosis (17) 17
france (15) 15
mortality (15) 15
respiratory system (15) 15
santé publique et épidémiologie (15) 15
research (14) 14
risk factors (14) 14
abridged index medicus (13) 13
adult (12) 12
cohort studies (12) 12
hospital mortality (11) 11
human health and pathology (11) 11
intensive-care-unit (11) 11
sepsis (11) 11
treatment outcome (10) 10
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (9) 9
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (9) 9
anesthesiology (9) 9
emergency medicine (9) 9
infectious diseases (9) 9
intensive care unit (9) 9
lung neoplasms - pathology (9) 9
medicine & public health (9) 9
intensive / critical care medicine (8) 8
intensive care units - statistics & numerical data (8) 8
survival (8) 8
analysis (7) 7
cancer (7) 7
follow-up studies (7) 7
icu (7) 7
management (7) 7
mesh: female (7) 7
mesh: humans (7) 7
mesh: male (7) 7
oncology (7) 7
pain medicine (7) 7
pediatrics (7) 7
pneumology/respiratory system (7) 7
risk (7) 7
risk assessment (7) 7
severity of illness index (7) 7
survival analysis (7) 7
[sdv.mhep]life sciences [q-bio]/human health and pathology (6) 6
care and treatment (6) 6
critical care (6) 6
critically-ill patients (6) 6
cross infection (6) 6
epidemiology (6) 6
health aspects (6) 6
infection (6) 6
lung neoplasms - genetics (6) 6
mesh: intensive care units (6) 6
mesh: middle aged (6) 6
neoplasm staging (6) 6
respiratory tract diseases (6) 6
septic shock (6) 6
anti-bacterial agents - therapeutic use (5) 5
blood-stream infections (5) 5
critical illness (5) 5
critically ill (5) 5
disease (5) 5
france - epidemiology (5) 5
incidence (5) 5
infections (5) 5
intensive care (5) 5
intensive-care units (5) 5
length of stay - statistics & numerical data (5) 5
mesh : humans (5) 5
mesh: aged (5) 5
microbiology (5) 5
multicenter (5) 5
proportional hazards models (5) 5
retrospective studies (5) 5
risk-factors (5) 5
time factors (5) 5
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (4) 4
adverse event (4) 4
aged, 80 and over (4) 4
bacteremia (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
critical care and intensive care medicine (4) 4
cross infection - drug therapy (4) 4
disease progression (4) 4
hematology, oncology and palliative medicine (4) 4
hospitals (4) 4
immunohistochemistry (4) 4
impact (4) 4
length of stay (4) 4
lung neoplasms - drug therapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Critical Care Medicine, ISSN 0090-3493, 08/2011, Volume 39, Issue 8, pp. 1886 - 1895
OBJECTIVES:We evaluated the respective influence of the causative pathogen and infection site on hospital mortality from severe sepsis related to community-,... 
pathogens | severe sepsis | Outcome | site of infection | place of acquisition | SURVIVAL | METHICILLIN RESISTANCE | PNEUMONIA | ANTIBIOTIC-THERAPY | ICU PATIENTS | CAUSATIVE MICROORGANISM | INTENSIVE-CARE-UNIT | ANTIMICROBIAL TREATMENT | outcome | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Multivariate Analysis | Prognosis | Prospective Studies | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Cross Infection - mortality | Male | Cause of Death | Hospital Mortality - trends | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Gram-Positive Bacteria - pathogenicity | Community-Acquired Infections - drug therapy | Shock, Septic - drug therapy | Female | Databases, Factual | Severity of Illness Index | Community-Acquired Infections - mortality | Intensive Care Units | Risk Assessment | Proportional Hazards Models | Survival Rate | Treatment Outcome | Shock, Septic - mortality | Cross Infection - drug therapy | Sepsis - mortality | Shock, Septic - microbiology | Drug Resistance, Microbial | Gram-Negative Bacteria - drug effects | Cross Infection - microbiology | Gram-Negative Bacteria - pathogenicity | Critical Care | Aged | Community-Acquired Infections - microbiology | Sepsis - microbiology | Cross Infection | Life Sciences | Anti-Bacterial Agents | Hospital Mortality | Gram-Negative Bacteria | Gram-Positive Bacteria | Human health and pathology | Shock, Septic | Sepsis | Intensive Care | Community-Acquired Infections
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2011, Volume 184, Issue 10, pp. 1133 - 1139
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 07/2013, Volume 188, Issue 1, pp. 69 - 76
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 10, pp. 1129 - 1136
Purpose Antiangiogenic therapies targeting the vascular endothelial growth factor (VEGF) pathway have yielded more modest clinical benefit to patients with... 
TARGETED THERAPY | PHASE-II TRIAL | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | MICROVESSEL DENSITY | PLUS CARBOPLATIN | VEGF RECEPTORS | PROGNOSTIC VALUE | CANCER | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Lung Neoplasms - drug therapy | Predictive Value of Tests | Up-Regulation | Prognosis | Adenocarcinoma of Lung | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Receptors, Vascular Endothelial Growth Factor - drug effects | Lung Neoplasms - pathology | Male | Vascular Endothelial Growth Factor A - metabolism | Adenocarcinoma - metabolism | Receptors, Vascular Endothelial Growth Factor - metabolism | Angiogenesis Inhibitors - therapeutic use | Biomarkers, Tumor - metabolism | Female | Vascular Endothelial Growth Factor A - drug effects | Odds Ratio | Lung Neoplasms - blood supply | Europe | Risk Factors | Proportional Hazards Models | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Treatment Outcome | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Disease Progression | Carcinoma, Squamous Cell - drug therapy | Analysis of Variance | Signal Transduction - drug effects | Carcinoma, Squamous Cell - blood supply | Aged | Neoplasm Staging | Cohort Studies | Thor12 | ORIGINAL REPORTS | To2 | To20 | To1
Journal Article
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 12/2012, Volume 186, Issue 12, pp. 1272 - 1278
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 12/2012, Volume 38, Issue 12, pp. 1930 - 1945
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 4/2014, Volume 40, Issue 4, pp. 582 - 591
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 8/2013, Volume 39, Issue 8, pp. 1396 - 1404
Missing values occur in nearly all clinical studies, despite the best efforts of the investigators, and cause frequently unrecognised biases. Our aims were (1)... 
Pediatrics | Missing data | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Bias | Intensive / Critical Care Medicine | ICU | Anesthesiology | Multiple imputation | Job strain | CRITICAL CARE MEDICINE | Intensive Care Units | Humans | Publishing - standards | Adult | Critical Care | Female | Male | Clinical trials | Research | Bias (Statistics) | Analysis | Methods
Journal Article
Journal Article